Cellular localization and activity of ad-delivered GFP-CFTR in airway epithelial and tracheal cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 37, Issue 6, 2007, Pages 631-639

  Granio, Ophélia ^a   Norez, Caroline ^b   Ashbourne Excoffon, Katherine J D ^c   Karp, Philip H ^c   Lusky, Monika ^d   Becq, Frédéric ^b   Boulanger, Pierre ^a,e   Zabner, Joseph ^c   Hong, Saw See ^a,f  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c UNIVERSITY OF IOWA   (United States)

^d TRANSGENE S A   (France)

^e HOSPICES CIVILS DE LYON   (France)

^f UNIVERSITÉ DE LYON   (France)

Author keywords

Adenovirus; CFTR deficient airway epithelia; Cl channel; Cystic fibrosis; GFP CFTR

Indexed keywords

ADENOVIRUS VECTOR; CHLORIDE CHANNEL; GREEN FLUORESCENT PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CELL CULTURE; CELL FUNCTION; CELL MEMBRANE; CELL MIGRATION; CELL TRANSPORT; CELLULAR DISTRIBUTION; CHIMERA; CYSTIC FIBROSIS; FUNCTIONAL ASSESSMENT; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; SIGNAL TRANSDUCTION; TRACHEA MUCOSA;

ADENOVIRIDAE;

EID: 36749031154     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2007-0026TE     Document Type: Article

References (30)

1. Davies JC, Geddes DM, Alton EWF. Gene therapy for cystic fibrosis. J Gene Med 2001;3:409-417.
2. Rowntree RK, Harris A. The phenotypic consequences of CFTR mutations. Ann Hum Genet 2003;67:471-485.
3. Riordan JR, Rommens JM, Kerem B-S. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073.
4. Imundo L, Barasch J, Prince A, Al-Awqati Q. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc Natl Acad Sci USA 1995;92:3019-3023.
5. Lee TWR, Matthews DA, Blair GE. Novel molecular approaches to cystic fibrosis gene therapy. Biochem J 2005;387:1-15.
6. Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis W, Boucher RC. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airway disease. Cell 1998;95:1005-1015.
7. Moyer BD, Loffing J, Schwiebert EM, Loffing-Cueni D, Halpin PA, Karlson KH, Ismailov II, Guggino WB, Langford GM, Stanton BA. Membrane trafficking of the cystic fibrosis gene product, cystic fibrosis transmembrane conducance regulator, tagged with green fluorescent protein in Madin-Darby Canine Kidney cells. J Biol Chem 1998;273:21759-21768.
8. Vais H, Gao G-P, Yang MPT, Louboutin J-P, Somananthan S, Wilson JM, Reenstra W. Novel adenoviral vectors coding for GFP-tagged wtCFTR and delF508-CFTR: characterization of expression and electrophysiological properties in A549 cells. Pflugers Arch Eur. J Physiol 2004;449:278-287.
9. Merten MD, Kammouni W, Renaud W, Birg F, Mattel MG, Figarella C. A transformed human tracheal gland cell line, MM-39, that retains serous secretory functions. Am J Respir Cell Mol Biol 1996;15:520-528.
10. Kammouni W, Moreau B, Becq F, Saleh A, Pavirani A, Figarella C, Merten MD. A cystic fibrosis tracheal gland cell line, CF-KM4. Correction by adenovirus-mediated CFTR gene transfer. Am J Respir Cell Mol Biol 1999;20:684-691.
11. Zabner J, Zeiher BG, Friedman E, Welsh MJ. Adenovirus-mediated gene transfer to ciliated airway epithelia requires prolonged incubation time. J Virol 1996;70:6994-7003.
12. Zabner J, Scheetz TE, Almabrazi HG, Casavant TL, Huang J, Keshavjee S, McCray PBJ. CFTR DF508 mutation has minimal effect on the gene expression profile of differentiated human airway epithelia. Am J Physiol Lung Cell Mol Physiol 2005;289: L545-L553.
13. Chartier C, Degryse E, Gantzer M, Dieterlé A, Pavirani A, Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 1996;70: 4805-4810.
14. Defer C, Belin MT, Caillet-Boudin ML, Boulanger P. Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. J Virol 1990;64:3661-3673.
15. Farmen SL, Karp PH, Ng P, Palmer DJ, Koehler DR, Hu J, Beaudet AL, Zabner J, Welsh MJ. Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR. Am J Physiol Lung Cell Mol Physiol 2005;289:L1123-L1130.
16. Zabner J, Couture LA, Gregory RJ, Graham SM, Smith AE, Welsh MJ. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelial of patients with cystic fibrosis. Cell 1993;75:207-216.
17. Zabner J, Karp P, Seiler M, Phillips SL, Mitchell CJ, Saavedra M, Welsh MJ, Klingelhutz AJ. Development of cystic fibrosis and noncystic fibrosis airway cell lines. Am J Physiol Lung Cell Mol Physiol 2003; 284:L844-L854.
18. Violot S, Hong SS, Rakotobe D, Petit C, Gay B, Moreau K, Billaud G, Priet S, Sire J, Schwartz O, et al. The human polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1. J Virol 2003;77:12507-12522.
19. Derand R, Bulteau-Pignoux L, Mettey Y, Zegarra-Moran O, Howell LD, Randak C, Galietta LJ, Cohn JA, Norez C, Romio L, et al. Activation of G551D CFTR channel with MPB-91: regulation by ATPase activity and phosphorylation. Am J Physiol Cell Physiol 2001;281:C1657-C1666.
20. Dormer RL, Derand R, McNeilly CM, Mettey Y, Bulteau-Pignoux L, Metaye T, Vierfond J, Gray MA, Galietta LJ, Morris MR, et al. Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells. J Cell Sci 2001;114:4073-4081.
21. Melin P, Thoreau V, Norez C, Bilan F, Kitzis A, Becq F. The cystic fibrosis mutation G1349D within the signature motif LSHGH of NBD2 abolishes the activation of CFTR chloride channels by genistein. Biochem Pharmacol 2004;67:2187-2196.
22. Venglarik CJ, Bridges RJ, Frizzell RA. A simple assay for agonist-regulated Cl and K conductances in salt-secreting epithelial cells. Am J Physiol 1990;259:C358-C364.
23. Ostedgaard LS, Randak C, Rokhlina T, Karp P, Vermeer D, Ashbourne Excoffon KJ, Welsh MJ. Effects of C-terminal deletions on cystic fibrosis transmembrane conductance regulator function in cystic fibrosis airway epithelia. Proc Natl Acad Sci USA 2003;100: 1937-1942.
24. Koehler DR, Hitt MM, Hu J. Challenges and strategies for cystic fibrosis lung gene therapy. Mol Ther 2001;4:84-91.
25. Rogers S, Wells R, Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 1986;234:364-368.
26. Rechsteiner M, Rogers SW. PEST sequences and regulation by proteolysis. Trends Biochem Sci 1996;21:267-271.
27. Johnson LG, Olsen JC, Sarkadi B, Moore KL, Swanstrom R, Boucher RC. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet 1992;2: 21-25.
28. Dorin JR, Farley R, Webb S, Smith SN, Farini E, Delaney SJ, Wainwright BJ, Alton EW, Porteous DJ. A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Ther 1996;3:797-801.
29. Gaden F, Franqueville L, Hong SS, Legrand V, Figarella C, Boulanger P. Mechanism of restriction of normal and cystic fibrosis transmembrane conductance regulator-deficient human tracheal gland cells to adenovirus (Ad) infection and Ad-mediated gene transfer. Am J Respir Cell Mol Biol 2002;27:628-640.
30. Gaden F, Franqueville L, Magnusson MK, Hong SS, Merten MD, Lindholm L, Boulanger P. Gene transduction and cell entry pathway of fiber-modified Adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells. J Virol 2004;78:7227-7247.